Kimia Biosciences Limited has appointed new cost, internal, and secretarial auditors to oversee its financial and regulatory compliance for the upcoming fiscal periods. The Board of Directors approved these appointments during a meeting held on August 1, 2026, in New Delhi, ensuring continuity in statutory audit functions under the Companies Act, 2013.

The Board appointed M/s Mahesh Singh & Co., Cost Accountants, as the Cost Auditor for Financial Year 2026-27 pursuant to Section 148 of the Companies Act, 2013 and the Companies (Cost Records and Audit) Rules, 2014. Simultaneously, M/s Chaudhry & Associates, Chartered Accountants (Firm Registration No. 033470N), was appointed as the Internal Auditor for Financial Year 2026-27 under Section 138 of the Companies Act, 2013 and the Companies (Accounts) Rules, 2014.

In a separate compliance move, the Board discontinued the services of M/s M & Co., Practising Company Secretaries, as Secretarial Auditor effective August 1, 2026. The company replaced them with M/s Maya Sharma and Associates, Practising Company Secretaries (Membership No. A52000), to conduct secretarial audits for Financial Years 2025-26 and 2026-27 under Section 204 of the Companies Act, 2013.

Auditor Appointments Overview

Firm Profiles and Experience

M/s Mahesh Singh & Co. brings over 25 years of experience in conducting audits for banks, companies, societies, and trusts. M/s Chaudhry & Associates has more than fifteen years of experience in internal audit and internal financial controls services. M/s Maya Sharma and Associates specializes in secretarial audits, certifications, consulting, and corporate compliance services.

The disclosures were made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Abhishek Kumar Pandey, Company Secretary and Compliance Officer, signed the disclosure on behalf of the company.

Kimia Biosciences Limited reported a 22.7% decline in net profit to ₹743.37 lakh for the financial year ended March 31, 2026, down from ₹961.24 lakh in the prior year. Revenue from operations decreased to ₹11,488.38 lakh compared to ₹11,892.08 lakh in FY25. The board approved the audited standalone financial results at its meeting held on May 29, 2026. The company submitted newspaper cuttings of the results, published in the Financial Express and Jansatta on May 31, 2026, to the BSE under Regulation 47 of the SEBI (LODR) Regulations, 2015.

For the quarter ended March 31, 2026, the company recorded a profit of ₹37.31 lakh, a significant drop from the ₹199.17 lakh reported in the corresponding quarter of the previous year. Revenue for the quarter stood at ₹2,719.98 lakh. Total expenses for the year increased to ₹10,804.54 lakh from ₹10,660.69 lakh in the previous year.

The statutory auditor, Neeraj Arora & Associates, issued an unmodified opinion on the financial statements. The auditor identified revenue recognition and research and development (R&D) expenditure as key audit matters. The report noted that the company reassessed its accounting treatment for certain R&D expenditures during the reporting period to comply with Ind AS 38, capitalizing costs that met the recognition criteria for intangible assets.

Financial Performance

The company’s earnings per share (EPS) for the year stood at ₹1.64, down from ₹2.04 in the previous year. Finance costs for the year reduced to ₹351.57 lakh from ₹455.70 lakh. The company did not declare any dividend for the year ended March 31, 2026.

Balance Sheet Highlights

The company’s total assets stood at ₹10,319.73 lakh as of March 31, 2026, down from ₹11,121.16 lakh a year earlier. Intangible assets increased significantly to ₹709.92 lakh from ₹237.82 lakh, primarily due to the capitalization of R&D costs. Borrowings, including non-current and current liabilities, totaled ₹3,462.79 lakh.

Regulatory Disclosures

The auditor confirmed that the company has maintained adequate internal financial controls over financial reporting. The report also noted that the company redeemed preference share capital amounting to ₹8 crore during the first and second quarters of the financial year in accordance with the terms of issue. The company used SAP Basics accounting software, which features an audit trail facility operated throughout the year.